Abstract
A randomized, prospective, double-blind, double-dummy, multicenter study investigated the efficacy and safety of 10 days of oral therapy with grepafloxacin at 400 mg once daily, grepafloxacin at 600 mg once daily, or ciprofloxacin at 500 mg twice daily in 624 patients with acute bacterial exacerbations of chronic bronchitis. At the end of treatment, clinical success (cure or improvement) was achieved for 93% (140 of 151), 88% (137 of 156), and 91% (145 of 160) of patients in the groups receiving grepafloxacin at 400 mg, grepafloxacin at 600 mg, and ciprofloxacin, respectively (clinically evaluable population). At follow-up (14 to 28 days posttreatment), the clinical success rates were 87% (124 of 143), 81% (122 of 151), and 80% (123 of 154) in the groups receiving grepafloxacin at 400 mg and 600 mg and ciprofloxacin, respectively. A total of 379 pathogens were isolated from 290 patients, with the most common isolates being Moraxella catarrhalis (21%), Staphylococcus aureus (20%), Haemophilus influenzae (18%), and Streptococcus pneumoniae (7%). For the evaluable population, successful bacteriologic response was obtained at the end of treatment for 96% (92 of 96), 98% (87 of 89), and 92% (82 of 90) of patients receiving grepaflox...Continue Reading
References
Mar 1, 1992·Antimicrobial Agents and Chemotherapy·T ImadaS Goto
Apr 1, 1992·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·H S SaderR N Jones
Jun 1, 1992·Antimicrobial Agents and Chemotherapy·H C NeuN X Chin
Jul 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P C Appelbaum
Dec 30, 1991·The American Journal of Medicine·S Chodosh
Nov 30, 1989·The American Journal of Medicine·S ChodoshD Pizzuto
Apr 1, 1986·European Journal of Clinical Microbiology·B I DaviesC Baur
Mar 1, 1995·Diagnostic Microbiology and Infectious Disease·D L SewellF Tenover
Feb 1, 1995·The Journal of Antimicrobial Chemotherapy·P J CookH Moudgil
Jan 1, 1995·The Journal of Antimicrobial Chemotherapy·G A PankuchP C Appelbaum
Mar 1, 1994·The Journal of Antimicrobial Chemotherapy·F MarcoR Frei
Jan 1, 1994·The Pediatric Infectious Disease Journal·F Baquero, E Loza
Aug 1, 1993·Antimicrobial Agents and Chemotherapy·G E Kenny, F D Cartwright
Apr 1, 1993·The Journal of Antimicrobial Chemotherapy·R WiseN Brenwald
Feb 1, 1993·The Journal of Antimicrobial Chemotherapy·S K SpanglerP C Appelbaum
Nov 1, 1995·Antimicrobial Agents and Chemotherapy·D HenryJ J Collins
May 1, 1996·Antimicrobial Agents and Chemotherapy·G V DoernA M Rauch
Sep 1, 1996·Diagnostic Microbiology and Infectious Disease·P C FuchsS D Brown
Jan 1, 1997·Clinical Pharmacokinetics·C EfthymiopoulosA Maroli
Nov 1, 1993·International Journal of Antimicrobial Agents·P Cole
Citations
Apr 9, 2001·Clinical Microbiology Reviews·S Sethi, T F Murphy
Dec 10, 1999·The Journal of Antimicrobial Chemotherapy·R WilsonB Sommerauer
Jan 16, 2002·Drugs·George G ZhanelDaryl J Hoban
Jul 31, 2019·Antibiotics·Benitta MathewsKavitha Saravu
Nov 30, 2000·Current Infectious Disease Reports·P Ball
Mar 10, 2001·Drugs & Aging·A Obaji, S Sethi
Jan 31, 2006·Expert Review of Anti-infective Therapy·Fernando J MartinezJeffrey Curtis
Jun 9, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Robert C Owens, Paul G Ambrose
Jul 23, 2003·The Journal of International Medical Research·M J ZervosB Leroy
May 21, 1998·Antimicrobial Agents and Chemotherapy·G A PankuchP C Appelbaum
Jul 29, 2008·Injury·Nicolas EfstathopoulosVassilios S Nikolaou